Pharmaceutical companies, healthcare providers, and clinical researchers in South Korea must comply with strict adverse event reporting requirements under the Pharmaceutical Affairs Act. This South Korea Pharmaceutical Adverse Event Report template helps you document suspected adverse drug reactions, safety concerns, and product quality complaints in accordance with MFDS (Ministry of Food and Drug Safety) regulations.

Whether you're a hospital pharmacist, clinical research organization, pharmaceutical manufacturer, or healthcare professional, maintaining accurate adverse event documentation is critical for patient safety and regulatory compliance. This template captures all essential information including patient demographics, product details, event descriptions, severity classifications, and reporter information required by Korean regulatory authorities.

Built with Paperform, this template offers conditional logic to streamline the reporting process—questions adapt based on event type, severity, and reporter role. You can customize notification workflows to alert your pharmacovigilance team immediately when serious adverse events are reported, and integrate with your safety database or quality management systems through Paperform's native integrations.

For pharmaceutical companies managing multiple products or clinical trials, Stepper (stepper.io) can automate your post-submission workflow—routing reports to the appropriate safety officers, triggering follow-up investigations, updating your safety database, and preparing regulatory submissions to MFDS within required timeframes.

This form template is designed specifically for the South Korean pharmaceutical industry, helping organizations maintain compliance while protecting patient safety through efficient adverse event monitoring and reporting.